Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
McKesson
Citi
Farmers Insurance
AstraZeneca
Dow
Fish and Richardson
Deloitte
QuintilesIMS

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,136,783

« Back to Dashboard

Summary for Patent: 6,136,783
Title: Antifungal compositions
Abstract:The invention is a pharmaceutical composition for intravenous administration to a patient comprising a) a pharmaceutically effective amount of a compound having the formula ##STR1## and the pharmaceutically acceptable salts thereof; b) a pharmaceutically acceptable amount of an excipient such as a bulking agent effective to form a lyophilized cake; and c) a pharmaceutically acceptable amount of acetate buffer effective to provide a pH of between about 4 and 7.
Inventor(s): Neururkar; Maneesh J. (Lansdale, PA), Kaufman; Michael J. (New Hope, PA), Hunke; William A. (Harleysville, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/333,245
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,136,783
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,136,783

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,136,783

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 006598 ➤ Try a Free Trial
Austria 241999 ➤ Try a Free Trial
Australia 2731197 ➤ Try a Free Trial
Australia 706250 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Citi
Cipla
Deloitte
Healthtrust
US Department of Justice
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.